Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Feb. 01, 2026
shares
| |
| Trading Arrangements, by Individual | |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Sumit Singh [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On January 16, 2026, Sumit Singh, the Company’s Chief Executive Officer, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and is scheduled to expire on January 29, 2027, subject to earlier termination in accordance with its terms. The aggregate number of shares of Class A common stock authorized to be sold pursuant to the trading arrangement is 612,185 shares.
|
| Name | Sumit Singh |
| Title | Chief Executive Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | January 16, 2026 |
| Expiration Date | January 29, 2027 |
| Arrangement Duration | 378 days |
| Aggregate Available | 612,185 |
| Aseemita Malhotra [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On January 16, 2026, Aseemita Malhotra, the Company’s President of Healthcare, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and is scheduled to expire on January 29, 2027, subject to earlier termination in accordance with its terms. The aggregate number of shares of Class A common stock authorized to be sold pursuant to the trading arrangement is 76,710 shares.
|
| Name | Aseemita Malhotra |
| Title | President |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | January 16, 2026 |
| Expiration Date | January 29, 2027 |
| Arrangement Duration | 378 days |
| Aggregate Available | 76,710 |